Jeff Borcherding, President of Immunovia’s US subsidiary since April 2022, has been the new Global CEO of Sweden’s Immunovia AB since the end of April.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Jeff_Borcherding_kl.jpg645574Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-05-09 15:49:002024-07-16 17:02:08Immunovia AB with new CEO